An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice.

Uncontrolled macrophage activation is now considered to be a critical event in the pathogenesis of chronic inflammatory diseases such as atherosclerosis, multiple sclerosis, and chronic venous leg ulcers. However, it is still unclear which environmental cues induce persistent activation of macrophages in vivo and how macrophage-derived effector molecules maintain chronic inflammation and affect resident fibroblasts essential for tissue homeostasis and repair. We used a complementary approach studying human subjects with chronic venous leg ulcers, a model disease for macrophage-driven chronic inflammation, while establishing a mouse model closely reflecting its pathogenesis. Here, we have shown that iron overloading of macrophages--as was found to occur in human chronic venous leg ulcers and the mouse model--induced a macrophage population in situ with an unrestrained proinflammatory M1 activation state. Via enhanced TNF-α and hydroxyl radical release, this macrophage population perpetuated inflammation and induced a p16(INK4a)-dependent senescence program in resident fibroblasts, eventually leading to impaired wound healing. This study provides insight into the role of what we believe to be a previously undescribed iron-induced macrophage population in vivo. Targeting this population may hold promise for the development of novel therapies for chronic inflammatory diseases such as chronic venous leg ulcers.

[1]  Werner Müller,et al.  Differential Roles of Macrophages in Diverse Phases of Skin Repair , 2010, The Journal of Immunology.

[2]  M. Salmon,et al.  A stromal address code defined by fibroblasts. , 2005, Trends in immunology.

[3]  G. Barbarini,et al.  Primary Pulmonary Hypertension in HIV Patients: A Systematic Review , 2001, Angiology.

[4]  S. Hanauer,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[5]  M. Robson,et al.  Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .

[6]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[7]  J. Sedivy,et al.  Cellular Senescence in Aging Primates , 2006, Science.

[8]  P. Libby,et al.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.

[9]  T. Krieg,et al.  Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. , 2000, The Journal of investigative dermatology.

[10]  H. Niederegger,et al.  Autocrine formation of hepcidin induces iron retention in human monocytes. , 2008, Blood.

[11]  R N Maini,et al.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. , 2000, The New England journal of medicine.

[12]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[13]  A. Salim The role of oxygen-derived free radicals in the management of venous (varicose) ulceration: A new approach , 1991, World journal of surgery.

[14]  H. Zeidler,et al.  Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial , 2002, The Lancet.

[15]  M. Streit,et al.  Topical application of the tumour necrosis factor‐α antibody infliximab improves healing of chronic wounds , 2006, International wound journal.

[16]  N. Rooijen,et al.  Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate , 1990, Cell and Tissue Research.

[17]  G M Lyons,et al.  Haemodynamic study examining the response of venous blood flow to electrical stimulation of the gastrocnemius muscle in patients with chronic venous disease. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[18]  Z. Ackerman,et al.  Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. , 1988, Archives of dermatology.

[19]  bc David J. Margolisa,et al.  Venous leg ulcer: incidence and prevalence in the elderly. , 2002, Journal of the American Academy of Dermatology.

[20]  Wei Li,et al.  The iron hypothesis of atherosclerosis and its clinical impact , 2003, Annals of medicine.

[21]  M. Davies,et al.  Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[22]  F. Gottrup,et al.  Immunohistochemical characterization of the cutaneous cellular infiltrate in different areas of chronic leg ulcers , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[23]  K. Krogfelt,et al.  Why chronic wounds will not heal: a novel hypothesis , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[24]  N. Carter,et al.  A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.

[25]  S. Goerdt,et al.  Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.

[26]  G. Moneta,et al.  Revision of the CEAP classification for chronic venous disorders: consensus statement. , 2004, Journal of vascular surgery.

[27]  Emmanuel A Theodorakis,et al.  Anti-TNF-alpha therapies: the next generation. , 2003, Nature reviews. Drug discovery.

[28]  D. Kipling,et al.  Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. , 2008, The Journal of investigative dermatology.

[29]  J. Gerber,et al.  Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. , 2001, Journal of immunology.

[30]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[31]  B. Halliwell,et al.  Iron, Atherosclerosis, and Neurodegeneration: A Key Role for Cholesterol in Promoting Iron‐Dependent Oxidative Damage? , 2004, Annals of the New York Academy of Sciences.

[32]  S. Tognazzo,et al.  Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. , 2005, Journal of vascular surgery.

[33]  G. Weiss,et al.  Cytokine Mediated Regulation of Iron Transport in Human Monocytic Cells , 2003 .

[34]  A. Lackner,et al.  CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier. , 2008, The American journal of pathology.

[35]  T. Breit,et al.  Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevity , 2009, Nature Cell Biology.

[36]  S. Tognazzo,et al.  The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. , 2006, Free radical biology & medicine.

[37]  R. Ross,et al.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.

[38]  N. Sharpless,et al.  Ink4a/Arf expression is a biomarker of aging. , 2004, The Journal of clinical investigation.

[39]  E. Zandi,et al.  Signaling Role of Intracellular Iron in NF-κB Activation* , 2003, The Journal of Biological Chemistry.

[40]  L. Zacharski,et al.  Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart disease , 2001, European journal of clinical investigation.

[41]  F. F. F. F. Aws S. Salim Ph.D. The role of oxygen-derived free radicals in the management of venous (varicose) ulceration: A new approach , 2005, World Journal of Surgery.

[42]  Jerry Kaplan,et al.  Regulation of iron acquisition and storage: consequences for iron-linked disorders , 2008, Nature Reviews Molecular Cell Biology.

[43]  Jiri Bartek,et al.  p16INK4A is a robust in vivo biomarker of cellular aging in human skin , 2006, Aging cell.

[44]  B. Hinz,et al.  Wound‐healing defect of CD18−/− mice due to a decrease in TGF‐β1 and myofibroblast differentiation , 2005, The EMBO journal.

[45]  T. Kepler,et al.  The T helper type 2 response to cysteine proteases requires dendritic cell–basophil cooperation via ROS-mediated signaling , 2010, Nature Immunology.

[46]  K. Scharffetter-Kochanek,et al.  Oxidative stress in chronic venous leg ulcers , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[47]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[48]  S. Raju,et al.  Clinical practice. Chronic venous insufficiency and varicose veins. , 2009, The New England journal of medicine.

[49]  R. Diegelmann,et al.  Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors , 1997, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[50]  M. Maves,et al.  Deferoxamine Decreases Necrosis in Dorsally Based Pig Skin Flaps , 1989, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[51]  Lyle L. Moldawer,et al.  Anti-TNF-α therapies: the next generation , 2003, Nature Reviews Drug Discovery.

[52]  V. Nizet,et al.  TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. , 2006, Blood.

[53]  H. Tsukamoto,et al.  Iron Causes Interactions of TAK1, p21ras, and Phosphatidylinositol 3-Kinase in Caveolae to Activate IκB Kinase in Hepatic Macrophages* , 2007, Journal of Biological Chemistry.

[54]  Csaba Szabó,et al.  Peroxynitrite: biochemistry, pathophysiology and development of therapeutics , 2007, Nature Reviews Drug Discovery.

[55]  M. Stacey,et al.  Iron and 8-isoprostane levels in acute and chronic wounds. , 2003, The Journal of investigative dermatology.

[56]  P. Smith Update on chronic-venous-insufficiency-induced inflammatory processes. , 2001, Angiology.

[57]  J. Duffield The inflammatory macrophage , 2003 .

[58]  R. Cooper,et al.  Use of topical corticosteroids on chronic leg ulcers. , 2007, Journal of wound care.

[59]  N. Van Rooijen,et al.  Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. , 2006, The Journal of clinical investigation.

[60]  W. Liles,et al.  The phagocytes: neutrophils and monocytes. , 2008, Blood.

[61]  P. Zamboni The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006, Journal of the Royal Society of Medicine.

[62]  J. Gerber,et al.  Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ Receptors1 , 2001, The Journal of Immunology.

[63]  S. Sato,et al.  Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. , 2000, The American journal of pathology.

[64]  J. Duffield The inflammatory macrophage: a story of Jekyll and Hyde. , 2003, Clinical science.

[65]  M. Robson Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .

[66]  K. Scharffetter-Kochanek,et al.  Protease inhibitors protect growth factor activity in chronic wounds , 1997, The British journal of dermatology.

[67]  J. Dormandy,et al.  Causes of venous ulceration: a new hypothesis , 1988 .

[68]  G. Schmid-Schönbein,et al.  Leukocyte activation in patients with venous insufficiency. , 1999, Journal of vascular surgery.

[69]  D. Margolis,et al.  Venous leg ulcer: incidence and prevalence in the elderly. , 2002, Journal of the American Academy of Dermatology.

[70]  F. Grinnell,et al.  Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. , 1993, The Journal of investigative dermatology.

[71]  B. Walzog,et al.  Wound healing defect of Vav3-/- mice due to impaired {beta}2-integrin-dependent macrophage phagocytosis of apoptotic neutrophils. , 2009, Blood.

[72]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[73]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[74]  M. Gotsman,et al.  Deferoxamine improves left ventricular function in beta-thalassemia. , 1986, Archives of internal medicine.

[75]  G. Dow,et al.  Infection in chronic wounds: controversies in diagnosis and treatment. , 1999, Ostomy/wound management.

[76]  K. Scharffetter-Kochanek,et al.  Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. , 2001, The Journal of investigative dermatology.

[77]  J. O’Shea,et al.  Cytokine signaling modules in inflammatory responses. , 2008, Immunity.

[78]  J. Menzoian,et al.  Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. , 1998, Journal of vascular surgery.

[79]  W. Eaglstein,et al.  Causes and effects of the chronic inflammation in venous leg ulcers. , 2000, Acta dermato-venereologica. Supplementum.

[80]  G. Riethmüller,et al.  Synergistic effect of tumor necrosis factor-? and interferon-? on collagen synthesis of human skin fibroblasts , 1989 .

[81]  Topical application of the tumour necrosis factor‐a antibody infliximab improves healing of chronic wounds , 2006 .

[82]  K. Harding,et al.  Non-healing is associated with persistent stimulation of the innate immune response in chronic venous leg ulcers. , 2010, Journal of dermatological science.

[83]  G. Riethmüller,et al.  Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on collagen synthesis of human skin fibroblasts in vitro. , 1989, Experimental Cell Research.

[84]  N. Rosenthal,et al.  A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair , 2009, Proceedings of the National Academy of Sciences.

[85]  R. Holmdahl,et al.  Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. , 2007, The Journal of clinical investigation.

[86]  G. Schmid-Schönbein,et al.  Chronic venous disease. , 2006, Minerva cardioangiologica.

[87]  C. McCollum,et al.  Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers , 2000, The Journal of pathology.

[88]  J. M. Cousin,et al.  Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. , 1999, Journal of immunology.

[89]  N. Van Rooijen,et al.  Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis , 2007, The Journal of experimental medicine.

[90]  J. Simon,et al.  Expression of the adhesion molecules ICAM-1, VCAM-1, and E-selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers. , 1996, Journal of the American Academy of Dermatology.

[91]  E. Zandi,et al.  Signaling role of intracellular iron in NF-kappaB activation. , 2003, The Journal of biological chemistry.

[92]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[93]  R. Tarnuzzer,et al.  Biochemical analysis of acute and chronic wound environments , 1996, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.